On the heels of a 14 percent hike in medical malpractice rates, Gov. Spitzer has directed his insurance superintendent to form a task force to “confront the fundamental drivers” of high medical-malpractice costs.

The task force will be headed by Insurance Superintendent Eric R. Dinallo, and members will include state Health Commissioner Richard F. Daines and what the Insurance Department’s news release described as “a broad range of representatives from physician and hospital associations, the insurance industry, consumer groups, health plans, trial lawyers and the Legislature.”

Assuming task force members have their minds and eyes open, they won’t have to look too hard for one obvious “driver” of high medical-malpractice rates.  As documented in this study by the Manhattan Institute’s Center for Legal Policy, the level of medical malpractice premiums in New York can be linked directly to the state’s large malpractice litigation awards.

Based on a statistical analysis of malpractice premiums and lawsuit awards throughout the nation, the study debunked the argument that high malpractice costs are a result of cyclical insurance-industry trends and price gouging.

Between 1999 and 2001, for example, New York had the nation’s second highest average medical malpractice premium at $42,916 per doctor, according to data compiled by the report’s authors. That was more than three times Vermont’s average and twice that of New Jersey’s, Connecticut’s, and Massachusetts.

The average medical malpractice premium in New York during that same period, meanwhile, was more than double the 50-state average of just over $20,000.

The report’s findings provide added evidence in support of medical malpractice reforms such as a cap on pain and suffering awards.  Such reforms have been introduced in the Legislature, but remain stalled in committee.

Tags:

About the Author

Tim Hoefer

Tim Hoefer is president & CEO of the Empire Center for Public Policy.

Read more by Tim Hoefer

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More